北方实验IPO前聘任80后新财务总监，5名副总均兼任沈阳工业大学外聘教师

Core Viewpoint - Northern Laboratory (Shenyang) Co., Ltd. has been accepted for IPO on the Beijing Stock Exchange, focusing on cybersecurity services and IT consulting, leveraging eight key technologies for its operations [1] Financial Performance - Total assets are projected to reach approximately 896.51 million yuan by the end of 2024, up from 677.13 million yuan in 2023 and 480.51 million yuan in 2022 [2] - Total equity is expected to increase to about 547.41 million yuan in 2024, compared to 434.64 million yuan in 2023 and 352.45 million yuan in 2022 [2] - Revenue is forecasted to grow from 280.14 million yuan in 2022 to 328.00 million yuan in 2023, and further to 367.66 million yuan in 2024 [2] - Net profit is anticipated to remain stable at approximately 112.71 million yuan in 2024, slightly down from 116.65 million yuan in 2023, and similar to 113.27 million yuan in 2022 [2] - The gross profit margin is projected to improve to 69.26% in 2024 from 67.63% in 2023 and 65.47% in 2022 [2] - The company's asset-liability ratio is expected to be 37.05% in 2024, up from 35.88% in 2023 and 26.84% in 2022 [2] Shareholding Structure - Yang Lichun directly holds 40.77% of the company, while Zhang Jiannan holds 21.32% directly and an additional 7.10% indirectly, giving them combined control over 85.22% of the voting rights [4] Management Team - The company has appointed a new financial director, Bai Jie, effective December 9, 2024, following the resignation of the previous director [6] - The management team consists of 11 senior executives, including 8 vice presidents, with terms running from November 2023 to November 2026 [5]